Stock 301075 TIBET DUO RUI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tibet Duo Rui Pharmaceutical Co., Ltd.

Equities

301075

CNE100004RW5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
19.65 CNY +0.20% Intraday chart for Tibet Duo Rui Pharmaceutical Co., Ltd. -1.45% -26.32%
Apr. 24 Tibet Duo Rui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 17 Tibet Duo Rui Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Tibet Duo Rui Pharmaceutical Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of chemical preparations and their active pharmaceutical ingredients (APIs). The Company's core product is sodium acetate ringer injection, which is mainly used to supplement body fluid, regulate electrolyte balance and correct acidosis. The Company's products also include its own products, compound electrolyte injection, compound mannitol injection and cefotaxime sodium for injection.

Number of employees: 395

Sales per Business

CNY in Million2022Weight2023Weight Delta
Preparation
70.2 %
298 74.3 % 235 70.2 % -21.22%
Pharmaceutical Distribution and Others
29.8 %
103 25.7 % 100 29.8 % -3.41%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
401 100.0 % 334 100.0 % -16.64%

Managers

Managers TitleAgeSince
Yong Deng CEO
 Chief Executive Officer 58 17-11-30
Chao Li DFI
 Director of Finance/CFO 45 17-04-30
Fen Jin BRD
 Director/Board Member 44 16-11-30
Tang Wang BRD
 Director/Board Member 47 18-08-31
Ying Liu IRC
 Investor Relations Contact 37 -
Bo Ao SEC
 Corporate Secretary 38 22-03-22

Members of the board

Members of the board TitleAgeSince
Ying Fei Liu BRD
 Director/Board Member 46 20-02-20
Yong Deng CEO
 Chief Executive Officer 58 17-11-30
Shao Zhong Zhang BRD
 Director/Board Member 68 16-11-30
Qin Deng BRD
 Director/Board Member 56 17-11-30
Fei Qi BRD
 Director/Board Member 47 20-02-20
Hong Wei Zhao CHM
 Chairman 53 20-05-27
Jia Li Zhou BRD
 Director/Board Member 40 20-02-20
Tang Wang BRD
 Director/Board Member 47 18-08-31
Fen Jin BRD
 Director/Board Member 44 16-11-30
Yun Guo Wang BRD
 Director/Board Member 52 22-04-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 80,000,000 23,080,949 ( 28.85 %) 0 28.85 %

Shareholders

NameEquities%Valuation
China Asset Management Co., Ltd.
0.9944 %
272,700 0.9944 % 734 329 ¥
Gfund Management Co., Ltd.
0.0755 %
20,700 0.0755 % 55 741 ¥
Nuode Asset Management Co., Ltd.
0.0266 %
7,300 0.0266 % 19 658 ¥
Hongde Fund Management Co., Ltd.
0.0197 %
5,400 0.0197 % 14 541 ¥
Fortune & Royal Asset Management Co., Ltd.
0.0179 %
4,900 0.0179 % 13 195 ¥
Broad Fund Management Co. Ltd.
0.0128 %
3,500 0.0128 % 9 425 ¥

Company contact information

Tibet Duo Rui Pharmaceutical Co., Ltd.

3/F, Building 1, Biomedical Park Zone A, Economic Dev Zone

854000, Chamdo

+

http://www.duoruiyy.com
address Tibet Duo Rui Pharmaceutical Co., Ltd.(301075)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
TIBET DUO RUI PHARMACEUTICAL CO., LTD. Stock Tibet Duo Rui Pharmaceutical Co., Ltd.
-26.32% 215M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 301075 Stock
  4. Company Tibet Duo Rui Pharmaceutical Co., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW